Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | PD 0360324 |
Trade Name | |
Synonyms | PD-0360324|PD0360324 |
Drug Descriptions |
PD 0360324 is a monoclonal antibody that targets CSF1 (M-CSF) and interferes with CSF1 receptor binding, which may result in increased anti-tumor immune response (PMID: 26376111). |
DrugClasses | CSF1 Antibody 2 |
CAS Registry Number | 1822383-05-0 |
NCIT ID | C131301 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Avelumab + PD 0360324 | Avelumab PD 0360324 | 0 | 1 |
Cyclophosphamide + PD 0360324 | Cyclophosphamide PD 0360324 | 0 | 1 |
PD 0360324 | PD 0360324 | 0 | 0 |